NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies

Anticancer Research

Volumn 34, Issue 6, 2014, Pages 3021-3030

  Ponti, Giovanni ^a   Martorana, Davide ^b   Pellacani, Giovanni ^a   Ruini, Cristel ^a   Loschi, Pietro ^a   Baccarani, Alessio ^a   De Santis, Giorgio ^a   Pollio, Annamaria ^c   Neri, Tauro Maria ^b   Mandel, Victor Desmond ^a   Maiorana, Antonio ^a   Maccio, Livia ^a   Maccaferri, Monia ^a   Tomasi, Aldo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Elephantiasis neuromatosa; GIST; malignant peripheral nerve sheet tumors; Neurofibromatosis type 1; Plexiform neurofibroma; NF1 truncating mutations

Indexed keywords

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CLINICAL ARTICLE; COLON CANCER; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIGESTIVE SYSTEM CANCER; DUODENUM CANCER; ELEPHANTIASIS; ELEPHANTIASIS NEUROMATOSA; FEMALE; FIRST DEGREE RELATIVE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; GERMLINE MUTATION; GLIOBLASTOMA; HUMAN; KIDNEY CANCER; MALE; MIDDLE AGED; NEUROFIBROMATOSIS; NF1 GENE; PANCREAS CANCER; PATHOGENESIS; PHENOTYPE; SOLID TUMOR; COHORT ANALYSIS; FAMILY; FOLLOW UP; GENETICS; GIST; MALIGNANT PERIPHERAL NERVE SHEET TUMORS; MUTATION; NEOPLASM; NEUROFIBROMA; NEUROFIBROMATOSIS TYPE 1; NF1 TRUNCATING MUTATIONS; PACHYDERMATOCELE; PATHOLOGY; PEDIGREE; PLEXIFORM NEUROFIBROMA; PROGNOSIS;

NEUROFIBROMIN;

ELEPHANTIASIS NEUROMATOSA; GIST; MALIGNANT PERIPHERAL NERVE SHEET TUMORS; NEUROFIBROMATOSIS TYPE 1; NF1 TRUNCATING MUTATIONS; PLEXIFORM NEUROFIBROMA;

ADULT; AGED; COHORT STUDIES; FAMILY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS; NEUROFIBROMA, PLEXIFORM; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; PEDIGREE; PHENOTYPE; PROGNOSIS;

EID: 84906309106     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Huson SM, Harper PS and Compston DA: Von Recklingausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 111: 1355-1381, 1988.
2. Korf BR: Plexiform neurofibromas. Am J Med Genet 89: 31-37, 1999.
3. Tonsgard JH, Yelavarthi KK, Cushner S, Short MP and Lindgren V: Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet 73: 80-86, 1997.
4. Ferner RE and Gutman DH: International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62: 1573-1577, 2002.
5. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E and Moran A: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39: 311-314, 2002.
6. Spittel RL, Fernando SE: A case of elephantiasis neuromatosa. Br Med J 1: 596-597, 1929.
7. Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I and Baralle D: A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 95: 233-238, 2006.
8. Brems H, Park C, Maertens O, Pemov A, Messiaen L, Upadhyaya M, Claes K, Beert E, Peeters K, Mautner V, Sloan JL, Yao L, Lee CC, Sciot R, De Smet L, Legius E and Stewart DR: Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association. Cancer Res 69: 7393-7401, 2009.
9. Evans DG, O'Hara C, Wilding A Ingham SL, Howard E, Dawson J, Moran A, Scott-Kitching V, Holt F and Huson SM: Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19: 1187-1191, 2011.
10. Ferguson VM and Kyle PM: Orbital plexiform neurofibroma. Br J Ophthalmol 77: 527-528, 1993.
11. Brorson H: From lymph to fat: liposuction as a treatment for complete reduction of lymphedema. Int J Low Extrem Wounds 11: 10-19, 2012.
12. Mautner VF, Kluwe L, Friedrich RE, Roehl AC, Bammert S, Högel J, Spöri H, Cooper DN and Kehrer-Sawatzki H: Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet 47: 623-630, 2010.
13. Ponti G, Losi L, Martorana D, Priola M, Boni E, Pollio A, Neri TM and Seidenari S: Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. Hered Cancer Clin Pract 9: 6, 2011.
14. De Luca A, Bottillo I, Dasdia MC, Morella A, Lanari V, Bernardini L, Divona L, Giustini S, Sinibaldi L, Novelli A, Torrente I, Schirinzi A, Dallapiccola B: Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. J Med Genet 44: 800-808, 2007.
15. De Luca A, Schirinzi A, Buccino A, Bottillo I, Sinibaldi L, Torrente I, Ciavarella A, Dottorini T, Porciello R, Giustini S, Calvieri S, Dallapiccola B: Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1. Hum Mutat 23: 629, 2004.
16. Pollock G: Report of a Case of Molluscum Fibrosum or Fibroma with observations. Med Chir Trans 56: 255-266, 1873.
17. Chiu H Y, Liao YH: Images in clinical medicine. Elephantiasis neuromatosa. N Engl J Med 368: 23, 2013.
18. De Raed T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R and Legius E: Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72: 1288-1292, 2003.
19. Mautner VF, Kluwe L, Friedrich RE, Roehl AC, Bammert S, Högel J, Spöri H, Cooper DN and Kehrer-Sawatzki H: Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet 47: 623-630, 2010.
20. Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, Lacombe D, Dollfus H, Pasquier L, Isidor B, Ferkal S, Soulier J, Sanson M, Dieux-Coeslier A, Bièche I, Parfait B, Vidaud M, Wolkenstein P, Upadhyaya M, Vidaud D; members of the NF France Network: Members of the NF France Network: NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 31: 1506-1518, 2010.
21. Zöller M, Rembeck B, Akesson HO and Angervall L: Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden. Acta Derm Venereol 75: 136-140, 1995.
22. Rasmussen SA, Yang Q and Friedman JM: Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68: 1110-1118, 2001.
23. Stiller CA, Chessells JM and Fitchett M: Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 70: 969-972: 1994.
24. Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E and Evans DG: Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44: 481-484, 2007.
25. Seminog OO and Goldacre MJ: Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. British Journal of Cancer 108: 193-198, 2013.
26. Wilson CH, Griffith CD, Shrimankar J and Douglas F: Gynaecomastia, neurofibromatosis and breast cancer. Breast 13: 77-79, 2004.
27. Madanikia SA, Bergner A, Ye X and Blakeley JO: Increased risk of breast cancer in women with NF1. Am J Med Genet A 158A: 3056-3060, 2012.
28. Pasmant E, Vidaud M, Vidaud D and Wolkenstein P: Neurofibromatosis type 1: from genotype to phenotype. J Med Genet 49: 483-489, 2012.
29. Vogt J, Kohlhase J, Morlot S Kluwe L, Mautner VF, Cooper DN and Kehrer-Sawatzki H: Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation. Hum Mutat 32: E2134-2147, 2011.
30. Castle B, Baser ME, Huson SM, Cooper DN and Upadhyaya M: Evaluation of genotype-phenotype correlations in neurofibro-matosis type 1. J Med Genet 40: e109, 2003.
31. Wiest V, Eisenbarth I, Schmegner C Krone W and Assum G: Somatic NF1 mutation spectra in a family with neurofibro-matosis type 1: toward a theory of genetic modifiers. Hum Mutat 22: 423-427, 2003.
32. Laycock-van Spyk S, Thomas N, Cooper DN and Upadhyaya M: Neurofibromatosis type 1-associated tumors: Their somatic mutational spectrum and pathogenesis. Hum Genomics 5: 623-690, 2011.
33. De Luca A, Buccino A, Gianni D, Mangino M, Giustini S, Richetta A, Divona L, Calvieri S, Mingarelli R, Dallapiccola B et al: NF1 gene analysis based on DHPLC. Hum Mutat 21: 171-172, 2003.